肌萎缩侧索硬化症中的呼吸功能障碍
Respiratory dysfunction in amyotrophic lateral sclerosis.
作者信息
Kaplan L M, Hollander D
机构信息
Department of Neurology, Tufts University School of Medicine, Boston, Massachusetts.
出版信息
Clin Chest Med. 1994 Dec;15(4):675-81.
PMID:7867282
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder of the voluntary motor system. Involvement of the respiratory system is inevitable and leads to the development of respiratory failure, the usual cause of death in this disorder. ALS at present is incurable, and only symptomatic treatment is available. This article presents guidelines for the recognition and management of respiratory failure.
摘要
肌萎缩侧索硬化症（ALS）是一种累及自主运动系统的进行性神经退行性疾病。呼吸系统受累不可避免，并会导致呼吸衰竭，这是该疾病常见的死因。目前，ALS无法治愈，仅能进行对症治疗。本文介绍了呼吸衰竭的识别与管理指南。
相似文献
1
Respiratory dysfunction in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的呼吸功能障碍
Clin Chest Med. 1994 Dec;15(4):675-81.
2
3
Respiratory system in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的呼吸系统
Neurol Clin. 1987 Feb;5(1):9-31.
4
5
[Respiratory insufficiency in amyotrophic lateral sclerosis and methods of treatment].[肌萎缩侧索硬化症中的呼吸功能不全及治疗方法]
Anesteziol Reanimatol. 1997 Nov-Dec(6):35-40.
6
[Types of ventilatory support and their indications in amyotrophic lateral sclerosis].[肌萎缩侧索硬化症的通气支持类型及其适应症]
Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S261-4S265.
7
Respiratory effects of amyotrophic lateral sclerosis: problems and solutions.肌萎缩侧索硬化症的呼吸影响：问题与解决方案
Respir Care. 2006 Aug;51(8):871-81; discussion 881-4.
8
Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.肌萎缩侧索硬化症：呼吸功能障碍的评估与治疗
Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Mar;3(1):5-13. doi: 10.1080/146608202317576480.
9
Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中皮质呼吸通路功能的电生理评估
Amyotroph Lateral Scler. 2010;11(1-2):57-62. doi: 10.1080/17482960903207385.
10
[Amyotrophic lateral sclerosis and respiratory assistance].
Rev Neurol (Paris). 1989;145(4):293-8.
引用本文的文献
1
Pulmonary care for ALS: Progress, gaps, and paths forward.肌萎缩侧索硬化症的肺部护理：进展、差距和前进道路。
Muscle Nerve. 2023 May;67(5):341-353. doi: 10.1002/mus.27779. Epub 2023 Jan 19.
2
Amyotrophic Lateral Sclerosis Genes in .肌萎缩侧索硬化症基因在...
Int J Mol Sci. 2021 Jan 18;22(2):904. doi: 10.3390/ijms22020904.
3
Diaphragmatic Neurophysiology and Respiratory Markers in ALS.肌萎缩侧索硬化症中的膈肌神经生理学与呼吸标志物
Front Neurol. 2019 Feb 21;10:143. doi: 10.3389/fneur.2019.00143. eCollection 2019.
4
Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols.肌萎缩侧索硬化症患者生存时长与无创通气启动及使用方案的相关性增加
Front Neurol. 2018 Jul 12;9:578. doi: 10.3389/fneur.2018.00578. eCollection 2018.
5
Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics.从利鲁唑到依达拉奉：二十年的历程——重新审视唯二两种肌萎缩侧索硬化症治疗药物的临床药代动力学。
Clin Pharmacokinet. 2018 Nov;57(11):1385-1398. doi: 10.1007/s40262-018-0655-4.
6
Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach.预测肌萎缩侧索硬化症早期延髓功能衰退：一种言语子系统方法
Behav Neurol. 2015;2015:183027. doi: 10.1155/2015/183027. Epub 2015 Jun 2.
7
Functional and morphological assessment of diaphragm innervation by phrenic motor neurons.膈运动神经元对膈肌神经支配的功能和形态学评估。
J Vis Exp. 2015 May 25(99):e52605. doi: 10.3791/52605.
8
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.盐酸右美沙芬 20 毫克/奎尼丁 10 毫克（NUEDEXTA(®)）治疗假性延髓情绪的综述。
Neurol Ther. 2014 Jun 17;3(1):15-28. doi: 10.1007/s40120-014-0018-5. eCollection 2014 Jun.
9
Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.脊髓内细胞移植用于靶向肌萎缩侧索硬化症和创伤性脊髓损伤中的颈髓腹角
J Vis Exp. 2011 Sep 18(55):3069. doi: 10.3791/3069.
10
Stem cell transplantation for spinal cord neurodegeneration.用于脊髓神经变性的干细胞移植。
Methods Mol Biol. 2011;793:479-93. doi: 10.1007/978-1-61779-328-8_31.
Zotero 插件